Share This Article:

Morphine has latent deleterious effects on the ventilatory responses to a hypoxic challenge*

Abstract Full-Text HTML Download Download as PDF (Size:628KB) PP. 166-180
DOI: 10.4236/ojmip.2013.34022    5,114 Downloads   8,235 Views   Citations

ABSTRACT

The aim of this study was to determine whether morphine depresses the ventilatory responses elicited by a hypoxic challenge (10% O2, 90% N2) in conscious rats at a time when the effects of morphine on arterial blood gas (ABG) chemistry, Alveolar-arterial (A-a) gradient and minute ventilation (Vm) had completely subsided. In vehicle-treated rats, each episode of hypoxia stimulated ventilatory function and the responses generally subsided during each normoxic period. Morphine (5 mg/kg, i.v.) induced an array of depressant effects on ABG chemistry, A-a gradient and Vm (via decreases in tidal volume). Despite resolution of these morphine-induced effects, the first episode of hypoxia elicited substantially smaller increases in Vm than in vehicle-treated rats, due mainly to smaller increases in frequency of breathing. The pattern of ventilatory responses during subsequent episodes of hypoxia and normoxia changed substantially in morphine-treated rats. It is evident that morphine haslatent deleterious effects on ventilatory responses elicited by hypoxic challenge.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

J. May, W. , B. Gruber, R. , F. Discala, J. , Puskovic, V. , Henderson Jr., F. , A. Palmer, L. and J. Lewis, S. (2013) Morphine has latent deleterious effects on the ventilatory responses to a hypoxic challenge*. Open Journal of Molecular and Integrative Physiology, 3, 166-180. doi: 10.4236/ojmip.2013.34022.

References

[1] Cepeda, M.S., Farrar, J.T., Baumgarten, M., Boston, R., Carr, D.B. and Strom, B.L. (2003) Side effects of opioids during short-term administration: Effect of age, gender, and race. Clinical Pharmacology and Therapeutics, 74, 102-112.
http://dx.doi.org/10.1016/S0009-9236(03)00152-8
[2] Cashman, J.N. and Dolin, S.J. (2004) Respiratory and haemodynamic effects of acute postoperative pain management: Evidence from published data. British Journal of Anaesthesia, 93, 212-223.
http://dx.doi.org/10.1093/bja/aeh180
[3] Taylor, S., Kirton, O.C., Staff, I. and Kozol, R.A. (2005) Postoperative day one: A high risk period for respiratory events. American Journal of Surgery, 190, 752-756.
http://dx.doi.org/10.1016/j.amjsurg.2005.07.015
[4] Lotsch, J., Dudziak, R., Freynhagen, R., Marschner, J. and Geisslinger, G. (2006) Fatal respiratory depression after multiple intravenous morphine injections. Clinical Pharmacokinetics, 45, 1051-1060.
http://dx.doi.org/10.2165/00003088-200645110-00001
[5] Peat, S.J., Hanna, M.H., Woodham, M., Knibb, A.A. and Ponte, J. (1991) Morphine-6-glucuronide: Effects on ventilation in normal volunteers. Pain, 45, 101-104.
http://dx.doi.org/10.1016/0304-3959(91)90170-3
[6] Berkenbosch, A., Teppema, L.J., Olievier, C.N. and Dahan, A. (1997) Influences of morphine on the ventilatory response to isocapnic hypoxia. Anesthesiology, 86, 1342-1349.
http://dx.doi.org/10.1097/00000542-199706000-00016
[7] Dahan, A., Sarton, E., Teppema, L. and Olievier, C. (1998) Sex-related differences in the influence of morphine on ventilatory control in humans. Anesthesiology, 88, 903-913.
http://dx.doi.org/10.1097/00000542-199804000-00009
[8] Sarton, E., Teppema, L. and Dahan, A. (1999) Sex differences in morphine-induced ventilatory depression reside within the peripheral chemoreflex loop. Anesthesiology, 90, 1329-1338.
http://dx.doi.org/10.1097/00000542-199905000-00017
[9] Fatemian, M., Nieuwenhuijs, D.J., Teppema, L.J., Meinesz, S., van der Mey, A.G., Dahan, A., Robbins, P.A. (2003) The respiratory response to carbon dioxide in humans with unilateral and bilateral resections of the carotid bodies. Journal of Physiology, 549, 965-973.
http://dx.doi.org/10.1113/jphysiol.2003.042259
[10] Timmers, H.J., Wieling, W., Karemaker, J.M. and Lenders, J.W. (2003) Denervation of carotid baro- and chemoreceptors in humans. Journal of Physiology, 553, 3-11.
http://dx.doi.org/10.1113/jphysiol.2003.052415
[11] Shook, J.E., Watkins, W.D. and Camporesi, E.M. (1990) Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression. American Review of Respiratory Disease, 142, 895-909. http://dx.doi.org/10.1164/ajrccm/142.4.895
[12] Satoh, M. and Minami, M. (1995) Molecular pharmacology of the opioid receptors. Pharmacology and Therapeutics, 68, 343-364.
http://dx.doi.org/10.1016/0163-7258(95)02011-X
[13] Haji, A., Takeda, R. and Okazaki, M. (2000) Neuropharmacology of control of respiratory rhythm and pattern in mature mammals. Pharmacology and Therapeutics, 86, 277-304.
http://dx.doi.org/10.1016/S0163-7258(00)00059-0
[14] Lewanowitsch, T. and Irvine, R.J. (2002) Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal. European Journal of Pharmacology, 445, 61-67.
http://dx.doi.org/10.1016/S0014-2999(02)01715-6
[15] Lewanowitsch, T., Miller, J.H. and Irvine, R.J. (2006) Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide. Life Sciences, 78, 682-688. http://dx.doi.org/10.1016/j.lfs.2005.05.062
[16] Campbell, C., Weinger, M.B. and Quinn, M. (1995) Alterations in diaphragm EMG activity during opiate-induced respiratory depression. Respiratory Physiology, 100, 107-117.
http://dx.doi.org/10.1016/0034-5687(94)00119-K
[17] Weinger, M.B. and Bednarczyk, J.M. (1994) Atipamezole, an alpha 2 antagonist, augments opiate-induced muscle rigidity in the rat. Pharmacology, Biochemistry and Behavior, 49, 523-529.
http://dx.doi.org/10.1016/0091-3057(94)90064-7
[18] Willette, R.N., Krieger, A.J. and Sapru, H.N. (1982) Opioids increase laryngeal resistance and motoneuron activity in the recurrent laryngeal nerve. European Journal of Pharmacology, 80, 57-63.
http://dx.doi.org/10.1016/0014-2999(82)90177-7
[19] Willette, R.N., Barcas, P.P., Krieger, A.J. and Sapru H.N. (1983) Pulmonary resistance and compliance changes evoked by pulmonary opiate receptor stimulation. European Journal of Pharmacology, 91, 181-188.
http://dx.doi.org/10.1016/0014-2999(83)90463-6
[20] Schurig, J.E., Cavanagh, R.L. and Buyniski, J.P. (1978) Effect of butorphanol and morphine on pulmonary mechanics, arterial blood pressure and venous plasma histamine in the anesthetized dog. Archives Internationales de Pharmacodynamie et de Thérapie, 233, 296-304.
[21] Zhang, Z., Xu, F., Zhang, C. and Liang, X. (2009) Opioid μ-receptors in medullary raphe region affect the hypoxic ventilation in anesthetized rats. Respiratory Physiology and Neurobiology, 168, 281-288.
http://dx.doi.org/10.1016/j.resp.2009.07.015
[22] McQueen, D.S. and Ribeiro, J.A. (1980) Inhibitory actions of methionine-enkephalin and morphine on the cat carotid chemoreceptors. British Journal of Pharmacology, 71, 297-305.
[23] Zimpfer, M., Beck, A., Mayer, N., Raberger, G. and Steinbereithner, K. (1983) Effects of morphine on the control of the cardiovascular system by the carotid-sinusreflex and by the carotid chemoreflex. Anaesthesist, 32, 60-66.
[24] Kirby, G.C. and McQueen, D.S. (1986) Characterization of opioid receptors in the cat carotid body involved in chemosensory depression in vivo. British Journal of Pharmacology, 88, 889-898.
http://dx.doi.org/10.1111/j.1476-5381.1986.tb16263.x
[25] Hargreaves, K., Dubner, R., Brown, F., Flores, C. and Joris, J. (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain, 32, 77-88.
http://dx.doi.org/10.1016/0304-3959(88)90026-7
[26] Rivat, C., Vera-Portocarrero, L.P., Ibrahim, M.M., Mata, H.P., Stagg, N.J., De Felice, M., Porreca, F. and Malan, T.P. (2009) Spinal NK-1 receptor-expressing neurons and descending pathways support fentanyl-induced pain hy- persensitivity in a rat model of postoperative pain. European Journal of Neuroscience, 29, 727-737.
http://dx.doi.org/10.1111/j.1460-9568.2009.06616.x
[27] Stein, P.D., Goldhaber, S.Z. and Henry, J.W. (1995) Alveolar-arterial oxygen gradient in the assessment of acute pulmonary embolism. Chest, 107, 139-143.
http://dx.doi.org/10.1378/chest.107.1.139
[28] Story, D.A. (1996) Alveolar oxygen partial pressure, alveolar carbon dioxide partial pressure, and the alveolar gas equation. Anesthesiology, 84, 1011.
http://dx.doi.org/10.1097/00000542-199604000-00036
[29] Kanbar, R., Stornetta, R.L., Cash, D.R., Lewis, S.J. and Guyenet, P.G. (2010) Photostimulation of Phox2b medullary neurons activates cardiorespiratory function in conscious rats. American Journal of Respiratory Critical Care Medicine, 182, 1184-1194.
http://dx.doi.org/10.1164/rccm.201001-0047OC
[30] Young, A.P., Gruber, R.B., Discala, J.F., May, W.J., Palmer, L.A. and Lewis, S.J. (2013) Co-activation of μ- and δ-opioid receptors elicits tolerance to morphine-induced ventilatory depression via generation of peroxynitrite. Respiratory Physiology and Neurobiology, 186, 255-264. http://dx.doi.org/10.1016/j.resp.2013.02.028
[31] Laferriere, A., Colin-Durand, J. and Moss I.R. (2005) Ontogeny of respiratory sensitivity and tolerance to the mu-opioid agonist fentanyl in rat. Developmental Brain Research, 156, 210-217.
http://dx.doi.org/10.1016/j.devbrainres.2005.03.002
[32] Fairchild, K.D., Saucerman, J.J., Raynor, L.L., Sivak, J.A., Xiao, Y., Lake, D.E. and Moorman, J.R. (2009) Endotoxin depresses heart rate variability in mice: Cytokine and steroid effects. American Journal of Physiology—Regulatory, Integrative and Comparative Physiology, 297, R1019-R1027.
http://dx.doi.org/10.1152/ajpregu.00132.2009
[33] Wallenstein, S., Zucker, C.L. and Fleiss, J.L. (1980) Some statistical methods useful in circulation research. Circulation Research, 47, 1-9.
http://dx.doi.org/10.1161/01.RES.47.1.1
[34] Quock, R.M., Vaughn, L.K., Barlament, J. and Wojcechowskyj, J.A. (1985) Sex and strain differences in morphine-induced temperature effects in WKYs and SHRs. Brain Research Bulletin, 14, 323-326.
http://dx.doi.org/10.1016/0361-9230(85)90192-3
[35] Jorenby, D.E., Keesey, R.E. and Baker, T.B. (1988) Characterization of morphine’s excitatory effects. Behavioral Neuroscience, 102, 975-985.
http://dx.doi.org/10.1037/0735-7044.102.6.975
[36] Haouzi, P., Bell, H.J., Notet, V. and Bihain, B. (2009) Comparison of the metabolic and ventilatory response to hypoxia and H2S in unsedated mice and rats. Respiratory Physiology and Neurobiology, 167, 316-322.
http://dx.doi.org/10.1016/j.resp.2009.06.006
[37] Mortola, J.P. and Saiki, C. (1996) Ventilatory response to hypoxia in rats: Gender differences. Respiratory Physiology, 106, 21-34.
[38] Baig, M.S. and Joseph, V. (2008) Age specific effect of MK-801 on hypoxic body temperature regulation in rats. Respiratory Physiology and Neurobiology, 160, 181-186.
http://dx.doi.org/10.1016/j.resp.2007.09.008
[39] Popio, K.A., Jackson, D.H., Ross, A.M., Schreiner, B.F. and Yu, P.N. (1978) Hemodynamic and respiratory effects of morphine and butorphanol. Clinical Pharmacology and Therapeutics, 23, 281-287.
[40] Mitaka, C., Sakanishi, N., Tsunoda, Y. and Mishima, Y. (1985) Comparison of hemodynamic effects of morphine, butorphanol, buprenorphine and pentazocine on ICU patients. The Bulletin of Tokyo Medical and Dental University, 32, 31-39.
[41] Lahiri, S., Roy A., Baby, S.M., Hoshi, T., Semenza, G.L. and Prabhakar, N.R. (2006) Oxygen sensing in the body. Progress in Biophysics and Molecular Biology, 91, 249-286. http://dx.doi.org/10.1016/j.pbiomolbio.2005.07.001
[42] Dempsey, J.A., Veasey, S.C., Morgan, B.J. and O’Don- nell, C. (2010) Pathophysiology of sleep apnea. Physiology Reviews, 90, 47-112.
[43] Teppema, L.J. and Dahan, A. (2010) The ventilatory response to hypoxia in mammals: Mechanisms, measurement, and analysis. Physiology Reviews, 90, 675-754.
http://dx.doi.org/10.1152/physrev.00012.2009
[44] Gozal, D., Gozal, E. and Simakajornboon, N. (2000) Signaling pathways of the acute hypoxic ventilatory response in the nucleus tractus solitarius. Respiratory Physiology, 121, 209-221.
http://dx.doi.org/10.1016/S0034-5687(00)00129-8
[45] Marczak, M., Kolesnikova, E.E. and Pokorski M. (2004) Hypoxic ventilatory profile in the anesthetized rat. Journal of Physiology and Pharmacology, 55, 89-94.
[46] Kongo, M., Yamamoto, R., Kobayashi, M. and Nosaka, S. (1999) Hypoxia inhibits baroreflex vagal bradycardia via a central action in anaesthetized rats. Experimental Physiology, 84, 47-56.
[47] Spyer, K.M. and Gourine, A.V. (2009) Chemosensory pathways in the brainstem controlling cardiorespiratory activity. Philosophical Transactions of the Royal Phiosophical Society, Series B: Biological Sciences, 364, 2603-2610. http://dx.doi.org/10.1098/rstb.2009.0082
[48] Smith, J.C., Abdala, A.P., Rybak, I.A. and Paton, J.F. (2009) Structural and functional architecture of respiratory networks in the mammalian brainstem. Philosophical Transactions of the Royal Phiosophical Society, Series B: Biological Sciences, 364, 2577-2587.
http://dx.doi.org/10.1098/rstb.2009.0081
[49] Badr, M.S., Skatrud, J.B. and Dempsey, J.A. (1992) Determinants of poststimulus potentiation in humans during NREM sleep. Journal of Applied Physiology, 73, 1958- 1971.
[50] Badr, M.S., Skatrud, J.B. and Dempsey, J.A. (1994) Effect of chemoreceptor stimulation and inhibition on total pulmonary resistance in humans during NREM sleep. Journal of Applied Physiology, 76, 1682-1692.
[51] Hayashi, F., Coles, S.K., Bach, K.B., Mitchell, G.S. and McCrimmon, D.R. (1993). Time-dependent phrenic nerve responses to carotid afferent activation: intact vs. decreebellate rats. American Journal of Physiology—Regulatory, Integrative and Comparative Physiology, 265, R811-R819.
[52] Coles, S.K. and Dick, T.E. (1996) Neurones in the ventrolateral pons are required for post-hypoxic frequency decline in rats. Journal of Physiology, 497, 79-94.
[53] Schlenker, E.H. and Prestbo, A. (2003) Elimination of the post-hypoxic frequency decline in conscious rats lesioned in pontine A5 region. Respiratory Physiology Neurobiology, 138, 179-191.
http://dx.doi.org/10.1016/S1569-9048(03)00187-3
[54] Hayashi, F. and Fukuda, Y. (2000) Neuronal mechanisms mediating the integration of respiratory responses to hypoxia. Japanese Journal of Physiology, 50, 15-24.
http://dx.doi.org/10.2170/jjphysiol.50.15
[55] Jodkowski, J.S., Coles, S.K. and Dick, T.E. (1997) Prolongation in expiration evoked from ventrolateral pons of adult rats. Journal of Applied Physiology, 82, 377-381.
[56] Dick, T.E. and Coles, S.K. (2000) Ventrolateral pons mediates short-term depression of respiratory frequency after brief hypoxia. Respiratory Physiology, 121, 87-100.
http://dx.doi.org/10.1016/S0034-5687(00)00121-3
[57] Stain, F., Barjavel, M.J., Sandouk, P., Plotkine, M., Scherrmann, J.M. and Bhargava, H.N. (1995) Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glu- curonide in the rat. Journal of Pharmacology and Experimental Therapeutics, 274, 852-857.
[58] Christrup, L.L. (1997) Morphine metabolites. Acta An- aesthesiologica Scandinavica, 41, 116-122.
http://dx.doi.org/10.1111/j.1399-6576.1997.tb04625.x
[59] Zheng, M., McErlane, K.M. and Ong, M.C. (1998) High-performance liquid chromatography-mass spectrometrymass spectrometry analysis of morphine and morphine metabolites and its application to a pharmacokinetic study in male Sprague-Dawley rats. Journal of Pharmaceutical and Biomedical Analysis, 16, 971-980.
http://dx.doi.org/10.1016/S0731-7085(97)00094-0
[60] Hasegawa, Y., Kishimoto, S., Shibatani, N., Nomura, H., Ishii, Y., Onishi, M., Inotsume, N., Takeuchi, Y. and Fukushima, S. (2010) The pharmacokinetics of morphine and its glucuronide conjugate in a rat model of streptozotocin-induced diabetes and the expression of MRP2, MRP3 and UGT2B1 in the liver. Journal of Pharmacy and Pharmacology, 62, 310-314.
http://dx.doi.org/10.1211/jpp.62.03.0004
[61] Fitzgerald, R.S., Eyzaguirre, C. and Zapata, P. (2009) Fifty years of progress in carotid body physiology—Invited article. Advances in Experimental Medicine and Bi- ology, 648, 19-28.
http://dx.doi.org/10.1007/978-90-481-2259-2_2
[62] Guyenet, P.G., Stornetta, R.L., Abbott, S.B., Depuy, S.D., Fortuna, M.G. and Kanbar, R. (2010) Central CO2-chem- oreception and integrated neural mechanisms of cardiovascular and respiratory control. Journal of Applied Physiology, 108, 995-1002.
http://dx.doi.org/10.1152/japplphysiol.00712.2009
[63] Johnson, A.K. and Gross, P.M. (1993) Sensory circumventricular organs and brain homeostatic pathways. FASEB Journal, 7, 678-686.
[64] Kilpatrick, G.J. and Smith, T.W. (2005) Morphine-6-glucuronide: Actions and mechanisms. Medicinal Research Reviews, 25, 521-544.
http://dx.doi.org/10.1002/med.20035
[65] Christensen, C.B. and Jargensen, L.N. (1987) Morphine- 6-glucuronide has high affinity for the opioid receptor. Pharmacology and Toxicology, 60, 75-76.
http://dx.doi.org/10.1111/j.1600-0773.1987.tb01724.x
[66] Oguri, K., Yamada-Mori, I., Shigezane, J., Hirano, T. and Yoshimura, H. (1987) Enhanced binding of morphine and nalorphine to opioid delta receptor by glucuronate and sulfate conjugations at the 6-position. Life Sciences, 41, 1457-1464.
http://dx.doi.org/10.1016/0024-3205(87)90710-7
[67] Gong, Q-L., Hedner, J., Bjorkman, R. and Hedner, T. (1992) Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat. Pain, 48, 249-255.
http://dx.doi.org/10.1016/0304-3959(92)90065-J
[68] Labella, F.S., Pinsky, C. and Havlicek, V. (1979) Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity. Brain Research, 174, 263-271.
http://dx.doi.org/10.1016/0006-8993(79)90849-7
[69] Smith, M.T., Watt, J.A. and Cramond, T. (1990) Morphine-3-glucuronide—A potent antagonist of morphine analgesia. Life Sciences, 47, 579-585.
http://dx.doi.org/10.1016/0024-3205(90)90619-3
[70] Yaksh, T.L., Harty, G.J., and Onofrio, B.M. (1986) High doses of spinal morphine produce a nonopiate receptor mediated hyperesthesia: Clinical and theoretic implications. Anesthesiology, 64, 590-597.
http://dx.doi.org/10.1097/00000542-198605000-00008
[71] Yaksh, T.L. and Harty, G.J. (1987) Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine. Journal of Pharmacology and Experimental Therapeutics, 244, 501-507.
[72] Bartlett, S.E., Cramond, T. and Smith, M.T. (1994) The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist and by midazolam, an antagonist at the benzodiazepine site on the GABAA receptor complex. Life Sciences, 54, 687-694.
http://dx.doi.org/10.1016/0024-3205(94)00552-4
[73] Kryger, M.H. (2000) Management of obstructive sleep apnea-hypopnea syndrome: Overview. In Kryger, M.H., Roth, T., Dement, W.C. and Saunders, W.B. (Eds.), Principles and Practice of Sleep Medicine, 3rd Edition, Philadelphia, 940-954.
[74] Lerman, J. (2006) Unraveling the mysteries of sleep-disordered breathing in children. Anesthesiology, 105, 645-647.
http://dx.doi.org/10.1097/00000542-200610000-00004
[75] Young, T., Peppard, P.E. and Gottlieb, D.J. (2002) Epidemiology of obstructive sleep apnea: a population health perspective. American Journal of Critical Care Medicine, 165, 1217-1239.
http://dx.doi.org/10.1164/rccm.2109080
[76] Dahan, A. (2007). Novel data on opioid effect on breathing and analgesia. Seminars in Anesthesia Perioperative Medicine and Pain, 26, 58-64.
http://dx.doi.org/10.1053/j.sane.2007.04.003
[77] Dahan, A. (2007) Respiratory depression with opioids. Journal of Pain and Palliative Care Pharmacotherapy, 21, 63-66. http://dx.doi.org/10.1080/J354v21n01_15
[78] Wang, D. and Teichtahl, H. (2007) Opioids, sleep architecture and sleep-disordered breathing. Sleep Medicine Reviews, 11, 35-46.
http://dx.doi.org/10.1016/j.smrv.2006.03.006

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.